Abstract
This review argues that cholecystokinin (CCK) and gastrin are incretins. The insulin cells are equipped with CCK2/gastrin receptors. CCK/gastrin peptides stimulate insulin secretion and potentiate the incretin effect of glucagon-like peptide-1. CCK/gastrin and insulin are released in significant amounts during normal mixed meals even at modest changes in blood glucose concentrations. Treatment of diabetes patients with combinatorial glucagon-like peptide-1 and CCK or gastrin-derived constructs therefore provides an expedient option.
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | Cardiovascular Endocrinology |
| Vol/bind | 5 |
| Udgave nummer | 3 |
| Sider (fra-til) | 99-101 |
| Antal sider | 3 |
| ISSN | 2162-688X |
| DOI | |
| Status | Udgivet - 2016 |
Fingeraftryk
Dyk ned i forskningsemnerne om 'Why cholecystokinin and gastrin are also incretins'. Sammen danner de et unikt fingeraftryk.Citationsformater
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS